Of the 400 hospitals and 382,236 cases analyzed from 2006 to 2010, 11 percent were performed under neuraxial anesthesia, 14.2 percent under a mix of neuraxial and general and 74.8 percent under general alone.
Researchers from Weill Cornell Medical College in New York City found neuraxial anesthesia decreased patients’ complications, length of stay, costs and 30-day mortality. However, patients who received neuraxial anesthesia were on average older than those patients receiving general anesthesia, according to the study.
More Articles on Anesthesia:
ASA Seeks Further Hardship Exemptions for Anesthesiologists
NAPA: Use STOP-BANG Questionnaire for Sleep Apnea Screening
Lippincott Williams & Wilkins Releases Mobile, Interactive Anesthesia E-Textbook
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
